SEC Form D · filed May 31, 2024
MyMD Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Christopher Schreiber · BALTIMORE, MDDirectorChris Chapman · BALTIMORE, MDExecJude Uzonwanne · BALTIMORE, MDDirectorIan Rhodes · BALTIMORE, MDExecMitchell J. Glass · BALTIMORE, MDDirectorBill J. White · BALTIMORE, MDDirectorCraig Eagle · BALTIMORE, MDDirectorJoshua Silverman · BALTIMORE, MDDirectorJonson Sun · Vancouver, British Columbia, CanadaDirectorAdam Siegler · NEW YORK, NYDirectorQuinn Mcarthur · Dover, DEDirectorMitchell J. Glass · BALTIMORE, MDDirectorEric Scharaga · Dover, DEDirectorBrian Cooper · Austin, TXExecMichael Crane · Austin, TXExecLaurence Kleinman · NEW YORK, NYDirectorCharles V. Welden, Iii · Birmingham, ALDirectorJohn Fichthorn · Norwalk, CTDirectorKenneth M. Larish · Nashville, TNExecRecof GP · Dallas, TXExecRegan Credit SLP · Dallas, TXDirectorJirka Rysavy · Louisville, CODirectorNed Preston · Louisville, CODirectorJill Cederberg · Fargo, NDDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗